However, recent studies have reported that IGFBP-2 is highly expressed in the serum of AD patients, and higher IGFBP-2 levels are only observed in amyloid-negative individuals with smaller hippocampal volumes. The gene discussed is IGFBP2; the disease is Alzheimer disease.